Literature DB >> 9459332

Relationship between thyroid hormones and plasma D-dimer levels.

R Chadarevian1, E Bruckert, A Ankri, I Beucler, P Giral, G Turpin.   

Abstract

High serum levels of cholesterol and triglycerides are risk factors for coronary heart disease and are strongly related to several haemostatic parameters. Thyroid disorders are a frequent feature in hyperlipidemic patients and are also associated with a variety of haemostatic abnormalities. Therefore, we analysed the relationships between free T4 (fT4) levels and Factor VII and VIII activities (FVIIc and FVIIc), D-Dimers (DDI) and Plasminogen Activator Inhibitor type 1 (PAI-1), in a group of 472 healthy patients referred for hyperlipidemia. Fourty patients were found to have primary hypothyroidism. A negative correlation was found in the whole study population between fT4 and DDI (p = 0.0001, r = -0.21) and the same results were found after exclusion of the patients with fT4 below the normal range (p = 0.0007, r = -0.17). In a multivariate regression analysis, the relationship between DDI and fT4 was independent of age, Body Mass Index (BMI), gender and total cholesterol. Less impressive correlation coefficients were found with FVIIc (r = -0.10), FVIIIc (r = -0.09) and PAI-1 (r = -0.09). These results suggest that fT4 may play a physiological role in the regulation of the haemostatic equilibrium in hyperlipidemic patients and that low levels of fT4 are associated with a hypercoagulable state.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459332

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study.

Authors:  Bregje van Zaane; Alessandro Squizzato; Roeland Huijgen; Anton P van Zanten; Eric Fliers; Suzanne C Cannegieter; Harry R Büller; Victor E A Gerdes; Dees P M Brandjes
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

Review 2.  Hemostasis and thyroid diseases revisited.

Authors:  M Franchini
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

4.  Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism.

Authors:  R Chadarevian; C Jublanc; E Bruckert; P Giral; A Ankri; L Leenhardt; J Chapman; G Turpin
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

5.  Thyroid function is associated with presence and severity of coronary atherosclerosis.

Authors:  J Auer; R Berent; T Weber; E Lassnig; B Eber
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 6.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

7.  Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.

Authors:  Huseyin Oflaz; Ramazan Kurt; Fatma Sen; Imran Onur; Arif Oguzhan Cimen; Ali Elitok; Kultigin Turkmen; Burak Pamukcu; Erdem Kasikcioglu; Zehra Bugra; Fehmi Mercanoglu; Nese Ozbey
Journal:  Endocrine       Date:  2008-01-26       Impact factor: 3.633

Review 8.  Coagulation and fibrinolysis in thyroid dysfunction.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

9.  Procoagulant and anticoagulant factors in childhood hypothyroidism.

Authors:  Nevin Kilic; Yildiz Dallar; Enver Simsek; Sirma Karamercan; Ayse Esra Tapci; Bulent Alioglu
Journal:  Int J Endocrinol       Date:  2012-07-03       Impact factor: 3.257

10.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.

Authors:  Bülent Alioğlu; Nevin Kılıç; Enver Şimşek; Yıldız Dallar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.